Meningitis News and Research

Latest Meningitis News and Research

Ghana launching childhood immunization campaign for rotavirus, pneumococcal disease

"Starting this week, Ghana will vaccinate the first babies in a new campaign against rotavirus -- a cause of severe diarrhea -- and pneumococcal disease, which causes pneumonia, meningitis and sepsis," Reuters reports.

27 Apr 2012

Eating disorders can be triggered by lack of support following traumatic events

Eating disorders can be triggered by lack of support following traumatic events such as bereavement, relationship problems, abuse and sexual assault, according to research published in the May issue of the Journal of Clinical Nursing. Even changing school or moving home can prove too much for some young people and lead to conditions such as anorexia or bulimia.

25 Apr 2012

Nigeria's first-ever national Vaccine Summit addresses child mortality burden

Nigeria's top government officials, civil society leaders and leaders of private industry resolved today to join forces to expand vaccine access nationwide, a major step in the fight to reduce child mortality in a country with the world's second highest number of child deaths.

24 Apr 2012

Herpes zoster vaccine safe and well tolerated: Study

The herpes zoster vaccine, also known as the shingles vaccine, is generally safe and well tolerated according to a Vaccine Safety Datalink study of 193,083 adults published online in the Journal of Internal Medicine.

23 Apr 2012

Paper points out decision-making capacity of patients with dementia

Luis Carlos álvaro, a clinical neurologist at the Hospital of Basurto (Bilbao) and lecturer at the University of the Basque Country (UPV/EHU), has had an article published on the capacity of patients with dementia to make decisions. It is entitled Competencia: conceptos generales y aplicación en la demencia (Competence: general concepts and application in dementia), and has been published in the journal Neurología.

17 Apr 2012

GAVI announces HPV, rubella vaccines will be available to developing countries

"The GAVI Alliance has announced that it will include human papillomavirus (HPV) and combined measles-rubella vaccines in its portfolio for the first time" to help protect women from cervical cancer and children from disability or premature death, Africa Science News reports.

6 Apr 2012

TAM protein complex - a potential antibacterial target

Scientists could produce new antibacterial treatments by disarming the molecular pumps bacteria use to bring disease causing molecules in contact with animals and humans.

6 Apr 2012

Young girls face increased risk of side effects after Gardasil vaccination

Younger girls are more likely than adult women to report side effects after receiving Gardasil, the human papillomavirus vaccine.

4 Apr 2012

New drive to prevent youngsters from inhaling second-hand smoke at home

There has a rise in the number of smokers despite the fewer public places at which to light up and one of the world's highest cigarette prices. Sales have hit a four-year high in 2009: 2.44 billion cigarettes, or 6.7 million a day. This was a 12-per-cent rise over 2008's figure of 2.17 billion sold; in 2005, it was 2.09 billion.

1 Apr 2012

CSL Behring commences enrollment in SCIg PATH trial for CIDP

CSL Behring has announced that the first patient has been enrolled in the PATH study, an international clinical trial designed to evaluate the efficacy, safety, and tolerability of two different doses of subcutaneous immunoglobulin (SCIg), compared with placebo, in maintenance treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).

26 Mar 2012

LSHTM professor receives Canada Gairdner Global Health Award

Sir Brian Greenwood, Manson Professor of Clinical Tropical Medicine at the London School of Hygiene & Tropical Medicine, has dedicated his career to saving children's lives by tackling malaria, meningitis and pneumonia - diseases which are dictated by the weather.

22 Mar 2012

Cote d'Ivoire working to rebuild health care system under new presidential administration

"Ten months after the West African country of Cote d'Ivoire started to emerge from a presidential election crisis during which almost all hospitals and clinics had to shut down for a good six months because they had been vandalized, looted and occupied, the new government under President Alassane Ouattara is trying to make public health care a priority," including implementing "a new national health regulation, which came into effect on Mar. 1, that offers free health services to pregnant women, children under five years and people suffering from malaria," Inter Press Service reports.

15 Mar 2012

Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints

Pfizer Inc. announced today that data from a Phase 3 study of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) met all study endpoints, showing immunogenicity and establishing a safety profile in children and adolescents aged 5 through 17 years.

12 Mar 2012

Top-line results from Inviragen's INV21 Phase 1 trial on HFMD

Inviragen today reported top-line results of a placebo-controlled, randomized Phase 1 trial of INV21, the Company's highly purified virus particle vaccine against Hand, Foot and Mouth Disease (HFMD) caused by enterovirus 71.

12 Mar 2012

Study: Bioavailability similar among four subcutaneous IgG preparations

Data presented by CSL Behring today suggest that the bioavailability of immunoglobulin G (IgG) therapies is consistent when patients with primary immunodeficiencies switch from one IgG product to another by the subcutaneous route.

5 Mar 2012

Bacteria may be talking to each other with a contact-dependent language

What if bacteria could talk to each other? What if they had a sense of touch? A new study by researchers at UC Santa Barbara suggests both, and theorizes that such cells may, in fact, need to communicate in order to perform certain functions. The findings appear today in the journal Genes & Development.

2 Mar 2012

Breakthrough discovery about Rhizobium radiobacter

A new discovery involving two Simon Fraser University scientists could lead to a little known and benign bacterium becoming a vital new tool in the development of a vaccine against human immunodeficiency virus.

29 Feb 2012

USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI

The International Vaccine Institute (IVI), an international organization based in Seoul devoted to research on the development and introduction of vaccines for the developing world, reached a milestone in its aim to prevent and control dysentery (also commonly called shigellosis or bloody diarrhea), a deadly disease that affects several million people worldwide.

27 Feb 2012

Intramuscular midazolam effective in treating status epilepticus

Drug delivery directly into muscle using an autoinjector is faster and may be more effective in stopping prolonged seizures, according to a study sponsored by the National Institutes of Health and conducted by a Wayne State University School of Medicine researcher.

17 Feb 2012

Benefits of long-term Kineret therapy in people with NOMID

A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease.

13 Feb 2012